State Street Corp Kiromic Biopharma, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.14 - $5.26 $2,376 - $89,293	-16,976 Closed	0 $0
Q3 2022 Nov 15, 2022	BUY	$0.26 - $0.57 $75 - $165	290 Added 1.74%	16,976 $5,000
Q3 2021 Nov 15, 2021	BUY	$2.69 - $4.94 $44,885 - $82,428	16,686 New	16,686 $51,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $34.7M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.